| 28756702 |
Kirby Schwartzbauer |
2026-10-23 18:14:36.185
|
Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs) (A57162) - R4 - Effective October 1, 2015 |
| 30466886 |
James Marko |
2026-10-23 15:29:42.916
|
NCCI Policy Manual Reminder |
| 30466868 |
James Marko |
2026-10-23 15:29:41.284
|
NCCI Policy Manual Reminder |
| 28748825 |
Kirby Schwartzbauer |
2026-10-23 18:14:47.695
|
Billing and Coding: MolDX: BCR-ABL (A55600)- R5 - Effective September 19, 2024 |
| 28735771 |
Kirby Schwartzbauer |
2026-10-23 18:14:57.051
|
Billing and Coding: MolDX: Blood Product Molecular Antigen Typing (A57376) - R5 - Effective October 1, 2024 |
| 28724299 |
Kirby Schwartzbauer |
2026-10-23 18:14:51.359
|
Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update (A54388) - R11 - Effective October 1, 2024 |
| 28654947 |
Kirby Schwartzbauer |
2026-10-23 18:14:44.228
|
Billing and Coding: MolDX: Afirma™ Assay by Veracyte (A54358) Retirement - Effective July 28, 2024 |
| 28654803 |
Kirby Schwartzbauer |
2026-10-23 18:14:09.948
|
Billing and Coding MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726) - R19 - Effective August 1, 2024 |
| 28609907 |
Kirby Schwartzbauer |
2026-10-23 18:14:40.886
|
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55323) - R17 - Effective July 1, 2024 |
